Why Asthma Research Matters Right Now
Asthma is not one disease but a collection of different inflammatory patterns, which is why a medication that works wonders for your neighbor might do very little for you. Researchers have spent years untangling these subtypes, and the result is a wave of targeted therapies—particularly biologics—that address specific inflammatory pathways rather than just calming symptoms temporarily.
The numbers tell a sobering story. According to the Asthma and Allergy Foundation of America, roughly one in twelve Americans has asthma, and adults account for more than 23 million of those cases. Women are affected at higher rates than men. Emergency department visits related to asthma topped 986,000 in a recent year, and hospital discharges exceeded 94,000. These figures underscore why asthma clinical trials are not just academic exercises—they are urgent efforts to find treatments that keep people out of the hospital and living the lives they want.
Many current studies focus on severe or uncontrolled asthma, particularly the eosinophilic type where certain white blood cells drive inflammation. Biologic medications like benralizumab, dupilumab, and tezepelumab have already changed the landscape for some patients, and newer trials are exploring whether these drugs can be dosed less frequently or even allow patients to reduce their daily maintenance inhalers.
What Kinds of Asthma Trials Are Available
The range of studies recruiting right now is broader than most people realize. Some trials test investigational medications that have never been approved, while others examine whether existing treatments can be used in new ways—for instance, giving a biologic injection once every six months instead of every two weeks. There are also studies that focus on technology, such as apps or sensors that monitor inhaler use and provide feedback to both patients and their doctors.
The following table gives a sense of what different categories of asthma trials tend to involve:
| Trial Type | Example Focus | Typical Duration | Compensation Range | Best For | Key Considerations |
|---|
| Phase II medication study | New biologic for eosinophilic asthma | 6–12 months | Modest stipend per visit | Those with moderate to severe uncontrolled asthma | Investigational drug may have unknown side effects |
| Phase III/IV medication study | Approved drug tested for new dosing schedule | 12–24 months | Higher compensation due to more visits | Patients already on standard therapy | Drug has prior safety data; placebo arm possible |
| Observational study | Tracking symptoms and lung function over time | 12–48 months | Lower per-visit stipend | Those who prefer not to take investigational drugs | No medication changes; purely data collection |
| Device or digital health study | Smart inhaler monitoring with app-based feedback | 3–12 months | Varies; often includes free device | Tech-comfortable patients interested in self-management | Minimal medication risk; privacy considerations apply |
| Pediatric prevention study | Preventing wheezing progression in young children | 2–4 years | Can reach several thousand dollars | Parents of children aged 2–12 with recurrent wheezing | Requires parental commitment to frequent visits |
Compensation varies widely by study length, visit frequency, and the institution running the trial. Shorter screening visits may offer a stipend in the range of $50 to $110, while longer-term studies at major research hospitals have been known to compensate participants up to several thousand dollars across the full study period. The Boston Children's Hospital Asthma Research Center, for example, has structured multi-year pediatric studies with total possible compensation reaching $2,560 for clinic visits and phone calls, with parking and transportation costs covered separately. Brigham and Women's Hospital has offered studies with compensation up to $3,900 for commitments spanning nearly two years and dozens of onsite visits. The key is that compensation reflects the time and inconvenience involved—longer studies with more procedures naturally pay more.
How to Find Asthma Clinical Trials Near You
ClinicalTrials.gov remains the most comprehensive database for finding studies in the United States. You can search by condition ("asthma"), location (your city or state), and recruitment status. Filtering for "Recruiting" and "Not yet recruiting" studies shows only those actively seeking participants.
Beyond the federal database, several other resources are worth exploring. Major academic medical centers—such as those affiliated with Harvard, Johns Hopkins, the University of California system, and the Cleveland Clinic—often maintain their own asthma research pages listing current studies. The American Lung Association also runs the Airways Clinical Research Centers network, which conducts asthma and COPD trials across multiple sites nationwide.
If you search for "asthma clinical trials near me," you will likely pull up local research clinics and hospital systems that specialize in respiratory studies. Keep in mind that some trials require in-person visits while others have adopted hybrid models with telehealth check-ins and at-home monitoring kits, a shift that accelerated during the pandemic and has since become a permanent option for many research programs.
Who Can Join and What to Expect
Eligibility criteria for asthma clinical trials vary, but most adult studies require a physician-confirmed asthma diagnosis, current use of at least one controller medication, and evidence that symptoms persist despite treatment. Some trials look specifically for people with frequent exacerbations, while others enroll patients with a particular eosinophil count or allergy profile.
You will not necessarily be excluded if you have other health conditions, but significant heart disease, certain liver or kidney issues, and a history of smoking above a certain threshold can rule you out. Each trial publishes its inclusion and exclusion criteria openly, and the research coordinator will walk you through them during the screening call.
The screening process itself typically involves a physical exam, blood work, breathing tests, and a detailed medical history review. Some studies also include allergy testing or a chest X-ray. If you qualify, the study team will present you with an informed consent document that spells out every procedure, visit, and potential risk. Read it carefully. Ask questions. A good research team expects and welcomes them.
Here are questions worth asking before you sign anything:
- How many visits are required, and how long does each one last?
- Will I need to stop taking any of my current medications?
- Is there a placebo arm, and what are the chances I will receive it?
- What happens if my asthma worsens during the trial?
- Who covers the cost of any emergency care related to the study?
- Can I continue seeing my regular pulmonologist or primary care doctor?
The informed consent process is not a one-time event. You can withdraw from a trial at any point, for any reason, without penalty. That right is protected by federal regulations, and research teams are required to remind you of it.
Weighing the Real Risks and Rewards
Joining a trial means accepting uncertainty. An investigational drug may not work for you, or it may cause side effects that were not seen in earlier, smaller studies. The placebo possibility is real in many trials, though some use an "add-on" design where all participants continue their usual medications and the investigational treatment or placebo is layered on top. That design means nobody goes without standard care.
The upside can be meaningful. Some participants gain access to therapies years before they reach the market. Others appreciate the extra medical attention—the regular lung function tests, the closer monitoring of symptoms, the chance to learn more about their own asthma patterns. And then there is the quieter reward of knowing your participation helps move the science forward for everyone else with the condition.
A patient named Sarah, who enrolled in a biologic trial at a Boston research center after years of relying on oral steroids, described the experience as "the first time in a decade I felt like someone was actually trying to solve the problem instead of just patching it." Her asthma did not disappear, but the frequency of her exacerbations dropped enough that she could return to hiking, something she had given up years earlier.
Practical Steps to Get Started
Begin by having an honest conversation with your current doctor. Some physicians are enthusiastic about clinical trials and can point you toward reputable studies. Others may be cautious, particularly if your asthma is well-controlled on existing therapy. Either way, your doctor should know if you are considering a trial, because the research team will likely need to coordinate with them.
Next, spend some time on ClinicalTrials.gov. Use the "Condition or disease" field to enter "asthma" and the "Country" filter to select "United States." Add your state or city in the "Other terms" field to narrow results geographically. Look for studies that match your asthma severity and treatment history. Each listing includes study locations, eligibility criteria, and contact information.
When you find a study that interests you, reach out to the listed coordinator by phone or email. Expect a brief screening conversation—they will ask about your diagnosis, medications, and general health. If you seem like a potential match, they will schedule a more thorough screening visit.
Before that visit, prepare a list of your current medications, including doses and how long you have been taking them. Bring any relevant medical records if you have them. And bring your questions—the ones listed above, plus any others specific to your situation.
The search for the right asthma clinical trial can take time, and not everyone qualifies for the first study they find. But persistence matters. The study that fits your situation may be recruiting now, or it may open enrollment in the coming months. Setting up a search alert on ClinicalTrials.gov is one way to stay informed without constantly checking.
Asthma research is moving faster than ever, and the participants who volunteer for these studies are the reason that progress is possible. Whether you are motivated by the chance to try a new treatment, the desire to contribute to medical knowledge, or simply the hope of breathing a little easier, the clinical trial landscape in the United States has more options than many people realize.
研究の知恵